TABLE 2.
Patient characteristics of the non‐deceased iMCD and deceased iMCD cohorts
| Characteristic | Deceased iMCD group (n = 6) | Non‐deceased iMCD group (n = 66) |
|---|---|---|
| Age at diagnosis, years: median (range) | 52.4 (15.2–66.7) | 37.3 (2.6–71.3) |
| Male, % | 50.0 | 53.0 |
| TAFRO cases, % | 83.3 | 51.5 |
| Histopathology, % | ||
| Hypervascular | 66.7 | 59.1 |
| Plasmacytic | 0.0 | 7.6 |
| Mixed | 16.7 | 28.8 |
| Not stated | 16.7 | 4.5 |
| Nationality, % | ||
| American | 66.7 | 89.4 |
| Other | 33.3 | 10.6 |
Abbreviations: iMCD, idiopathic multicentric Castleman disease; TAFRO, thrombocytopenia, anasarca, fever, reticulin myelofibrosis, renal dysfunction and organomegaly.